PathCentral

About PathCentral

PathCentral, founded in 2009, operated as a technology company based in Irvine, California, providing software solutions and services tailored for the pathology community. The company was acquired by XIFIN, Inc. in August 2013. PathCentral secured $14.9 million in total funding over three rounds from institutional investors, including Baird Capital, Arboretum Ventures, and Okapi Venture Capital.

The company's core offering was a web-based Anatomic Pathology Laboratory Information System (APLIS) named AP Anywhere. This platform was designed to integrate the critical operational components of a pathology practice, such as test ordering, laboratory workflow management, specimen tracking, transcription, reporting, and billing into a single, cohesive system. A key feature was its web-based architecture, which allowed pathologists to access the system and manage cases from anywhere using devices like laptops, tablets, and smartphones, all within a secure, HIPAA-compliant environment. The system was built to be scalable, leveraging technology that had been used by high-volume commercial labs for over a decade.

In addition to its LIS, PathCentral developed PathCentralPro.net, a comprehensive online information exchange and global digital consultation forum. This network enabled pathologists to upload digital images of case files to collaborate with and receive secondary consult diagnoses from colleagues worldwide. The platform was designed to be agnostic to specific scanning and imaging software, promoting an open environment to connect pathologists globally. This initiative aimed to enhance access to specialized pathology expertise and improve turnaround times, particularly for cancer patients, by reducing the need to physically transport tissue samples and slides. At the time of its acquisition, PathCentral's network had gained significant traction, with members from prominent institutions like Johns Hopkins, Massachusetts General Hospital, and Penn Medicine.